393 related articles for article (PubMed ID: 31784042)
1. Cardio-oncological management of patients.
Cardinale DM; Barac A; Torbicki A; Khandheria BK; Lenihan D; Minotti G
Semin Oncol; 2019 Dec; 46(6):408-413. PubMed ID: 31784042
[TBL] [Abstract][Full Text] [Related]
2. Cardio-oncology in clinical studies and real life.
Dent SF; Suter TM; López-Fernández T; Opolski G; Menna P; Minotti G
Semin Oncol; 2019 Dec; 46(6):421-425. PubMed ID: 31767270
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology.
Yeh ETH; Ewer MS; Moslehi J; Dlugosz-Danecka M; Banchs J; Chang HM; Minotti G
Semin Oncol; 2019 Dec; 46(6):397-402. PubMed ID: 31753424
[TBL] [Abstract][Full Text] [Related]
4. Helping the cardio-oncologist: from real life to guidelines.
Armenian SH; Jurczak W; Carver JR; Gennari A; Minotti G; Ewer MS
Semin Oncol; 2019 Dec; 46(6):433-436. PubMed ID: 31784041
[TBL] [Abstract][Full Text] [Related]
5. Strategies to Prevent Cardiotoxicity.
Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms and clinical course of cardiovascular toxicity of cancer treatment II. Hematology
Breccia M; Carver JR; Szmit S; Jurczak W; Salvatorelli E; Minotti G
Semin Oncol; 2019 Dec; 46(6):403-407. PubMed ID: 31748121
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular events in cancer survivors.
Howard E; Steingart RM; Armstrong GT; Lyon AR; Armenian SH; Teresa Voso M; Cicconi L; Coco FL; Minotti G
Semin Oncol; 2019 Dec; 46(6):426-432. PubMed ID: 31791551
[TBL] [Abstract][Full Text] [Related]
8. Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods.
Kuang Z; Kong M; Yan N; Ma X; Wu M; Li J
Curr Treat Options Oncol; 2024 May; 25(5):679-701. PubMed ID: 38676836
[TBL] [Abstract][Full Text] [Related]
9. Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome.
Tilemann LM; Heckmann MB; Katus HA; Lehmann LH; Müller OJ
Clin Res Cardiol; 2018 Apr; 107(4):271-280. PubMed ID: 29453595
[TBL] [Abstract][Full Text] [Related]
10. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
[TBL] [Abstract][Full Text] [Related]
11. Old and new directions of Cardio-Oncology.
Ewer MS; Carver JR; Minotti G
Semin Oncol; 2019 Dec; 46(6):395-396. PubMed ID: 31767271
[No Abstract] [Full Text] [Related]
12. Optimizing cardio-oncology programs for cancer patients.
Francis SA; Asnani A; Neilan T; Scherrer-Crosbie M
Future Oncol; 2015; 11(14):2011-5. PubMed ID: 26198828
[No Abstract] [Full Text] [Related]
13. Cardio-oncology: an ongoing evolution.
Petek BJ; Greenman C; Herrmann J; Ewer MS; Jones RL
Future Oncol; 2015; 11(14):2059-66. PubMed ID: 26198836
[TBL] [Abstract][Full Text] [Related]
14. [Cardiotoxicity of anticancer therapies. Towards the implementation of cardio-oncology units].
Hameau R; Gabrielli L; Garrido M; Guzmán AM; Retamal I; Vacarezza MJ; Greig D; Ocqueteau M; Sánchez C; Pizarro M; Corvalán A; Lavandero S; Castro PF; Martínez G
Rev Med Chil; 2018 Jan; 146(1):68-77. PubMed ID: 29806680
[TBL] [Abstract][Full Text] [Related]
15. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
Tajiri K; Aonuma K; Sekine I
Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
[TBL] [Abstract][Full Text] [Related]
16. Cardio-oncology imaging tools at the translational interface.
Yaros K; Eksi B; Chandra A; Agusala K; Lehmann LH; Zaha VG
J Mol Cell Cardiol; 2022 Jul; 168():24-32. PubMed ID: 35385715
[TBL] [Abstract][Full Text] [Related]
17. Cardio-oncology for the 21st century: introduction.
Schwartz ML
Semin Oncol; 2013 Apr; 40(2):145-6. PubMed ID: 23540739
[No Abstract] [Full Text] [Related]
18. Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues.
Zambelli A; Della Porta MG; Eleuteri E; De Giuli L; Catalano O; Tondini C; Riccardi A
Breast; 2011 Apr; 20(2):176-83. PubMed ID: 21146409
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular adverse effects of targeted antiangiogenic drugs: mechanisms and management.
Sundararajan S; Kumar A; Poongkunran M; Kannan A; Vogelzang NJ
Future Oncol; 2016; 12(8):1067-80. PubMed ID: 26901457
[TBL] [Abstract][Full Text] [Related]
20. Current and emerging modalities for detection of cardiotoxicity in cardio-oncology.
Khouri MG; Klein MR; Velazquez EJ; Jones LW
Future Cardiol; 2015 Jul; 11(4):471-84. PubMed ID: 26235924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
